Modeling the intact form of the alpha 1-proteinase inhibitor.
The structure of the intact form of the serpin alpha 1-proteinase inhibitor has been modeled based on the assumption that the central strand s4A of the six-stranded beta-sheet A of the cleaved inhibitor is not incorporated into the sheet of intact alpha 1-proteinase inhibitor. This strand was removed from its position in the center of the sheet by suitable rotations about the backbone dihedrals of Lys343 using molecular graphics. The resulting structure was then annealed using molecular dynamics (MD) while applying progressive distance restraints to the reactive peptide bond (Met358-Ser359) for 50 ps. During this time, the disrupted beta-sheet reformed to create a five-stranded beta-sheet with strands 3 and 5 in a parallel arrangement. This change and accompanying structural rearrangements are largely confirmed by the X-ray structure of plakalbumin, whose structure reflects the overall structure of intact serpins. The successful modeling experiment demonstrates the utility of MD for making gross structural predictions based on related structures. The binding loop of the intact form is modeled to allow docking with serine proteinases, in particular thrombin, which most highly constrains the possible conformations of the binding loop.
Engh
R A
RA
Max Planck Institut für Biochemie, Martinsried bei München, FRG.
Wright
H T
HT
Huber
R
R
D008956:Models, Chemical; D010047:Ovalbumin; D010196:Pancreatic Elastase; D010446:Peptide Fragments; D011480:Protease Inhibitors / Q000493:pharmacokinetics; D011487:Protein Conformation; D011506:Proteins; D015843:Serpins; D013237:Stereoisomerism; D013917:Thrombin; D014357:Trypsin
D010446:Peptide Fragments; D011480:Protease Inhibitors; D011506:Proteins; D015843:Serpins; C038141:plakalbumin; D010047:Ovalbumin; D010196:Pancreatic Elastase; D014357:Trypsin; D013917:Thrombin